SLITRK5 is a cellular protein whose normal function appears to suppress bone formation and could be a potential new target for the treatment ofosteoporosis, according to a collaborative study conducted by Weill Cornell Medicine and NewYork-Presbyterian researchers.
Cells manifesting the SLITRK5 protein are marked with magenta (left) and a bone-forming osteoblast marker in green (center). These markers were observed in the cancellous bone in the medulla space (top) or on the outer layer covering the bone (bottom). The overlap between these two markers (right) shows that SLITRK5 is found in bone-forming osteoblasts but not in other cell types, helping to make SLITRK5 a target for skeletal disease treatment. Credit: Dr. Matthew Greenblatt and Dr. Jun Sun
There Research was published in the scientific journal Nature Communications.
Read Also
- Dragon Ball Super: this XL Super Saiyan Vegeta Blue collector figurine is canon May 29, 2022
- F1 / GP Holland 2021, PL2: Leclerc opens the Ferrari double – LIVE | FormulaPassion.it Sep 3, 2021
- Wir haben dich vermisst | FormulaPassion.it Aug 31, 2021
- MotoGP / Pol Espargarò: a tough confrontation with Puig behind the rebirth | FormulaPassion.it Sep 1, 2021
- Two Colombians were captured for bringing cocaine through ‘narcowigs’ to Panama Jun 5, 2022
- the dynamic revision of an iconic villain May 26, 2021
- Hacking A Russian hacking group that paralyzed the Swedish supermarket chain and more than a thousand other companies suddenly Jul 14, 2021